Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 802

1.

Obesity: Pathophysiology, monosodium glutamate-induced model and anti-obesity medicinal plants.

Hernández Bautista RJ, Mahmoud AM, Königsberg M, López Díaz Guerrero NE.

Biomed Pharmacother. 2018 Dec 28;111:503-516. doi: 10.1016/j.biopha.2018.12.108. [Epub ahead of print] Review.

2.

The effects of Z56822977 on biosynthesis of serotonin in the brain of rats in the conditions of MSG-induced obesity.

Konopelniuk V, Falalyeyeva T, Tsyryuk O, Savchenko Y, Kobyliak N, Prybytko I, Kovalchuk O, Boyko A, Arkhipov VV, Moroz Y, Ostapchenko L.

Endokrynol Pol. 2018;69(5):536-544. doi: 10.5603/EP.2018.0058.

3.

Monosodium Glutamate (MSG)-Induced Animal Model of Type 2 Diabetes.

Bahadoran Z, Mirmiran P, Ghasemi A.

Methods Mol Biol. 2019;1916:49-65. doi: 10.1007/978-1-4939-8994-2_3.

PMID:
30535681
4.

Most Women with Previous Gestational Diabetes Mellitus Have Impaired Glucose Metabolism after a Decade.

Wahlberg J, Ekman B, Arnqvist HJ.

Int J Mol Sci. 2018 Nov 23;19(12). pii: E3724. doi: 10.3390/ijms19123724.

5.

In vitro bioassay investigations of suspected obesogen monosodium glutamate at the level of nuclear receptor binding and steroidogenesis.

Shannon M, Wilson J, Xie Y, Connolly L.

Toxicol Lett. 2019 Feb;301:11-16. doi: 10.1016/j.toxlet.2018.10.021. Epub 2018 Oct 28.

PMID:
30394305
6.

Higher intakes of energy-adjusted dietary amino acids are inversely associated with obesity risk.

Okekunle AP, Wu X, Feng R, Li Y, Sun C.

Amino Acids. 2018 Oct 30. doi: 10.1007/s00726-018-2672-x. [Epub ahead of print]

PMID:
30377838
7.

Small intestine barrier function failure induces systemic inflammation in monosodium glutamate-induced chronically obese mice.

Nakadate K, Hirakawa T, Tanaka-Nakadate S.

Appl Physiol Nutr Metab. 2018 Oct 21. doi: 10.1139/apnm-2018-0560. [Epub ahead of print]

PMID:
30345803
8.

Glucose intolerance in monosodium glutamate obesity is linked to hyperglucagonemia and insulin resistance in α cells.

Araujo TR, da Silva JA, Vettorazzi JF, Freitas IN, Lubaczeuski C, Magalhães EA, Silva JN, Ribeiro ES, Boschero AC, Carneiro EM, Bonfleur ML, Ribeiro RA.

J Cell Physiol. 2018 Oct 14. doi: 10.1002/jcp.27455. [Epub ahead of print]

PMID:
30317580
9.

Anaemogenic, Obesogenic And Thermogenic Potentials Of Graded Doses Of Monosodium Glutamate Sub-Acutely Fed To Experimental Wistar Rats.

Salisu N, Aliyu FS, Garba H, Garba MH.

Curr Clin Pharmacol. 2018 Oct 2. doi: 10.2174/1574884713666181002120657. [Epub ahead of print]

PMID:
30277163
10.

Patho-physiological and Toxicological Aspects of Monosodium Glutamate.

Chakraborty SP.

Toxicol Mech Methods. 2018 Oct 1:1-35. doi: 10.1080/15376516.2018.1528649. [Epub ahead of print]

PMID:
30273089
11.

The toxic effects of monosodium glutamate (MSG) - The involvement of nitric oxide, prostanoids and potassium channels in the reactivity of thoracic arteries in MSG-obese rats.

Majewski M, Jurgoński A, Fotschki B, Juśkiewicz J.

Toxicol Appl Pharmacol. 2018 Nov 15;359:62-69. doi: 10.1016/j.taap.2018.09.016. Epub 2018 Sep 19.

PMID:
30244120
12.

Phthalate exposure and childhood overweight and obesity: Urinary metabolomic evidence.

Xia B, Zhu Q, Zhao Y, Ge W, Zhao Y, Song Q, Zhou Y, Shi H, Zhang Y.

Environ Int. 2018 Dec;121(Pt 1):159-168. doi: 10.1016/j.envint.2018.09.001. Epub 2018 Sep 9.

PMID:
30208345
13.

Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance.

Tiberti C, Zampetti S, Capoccia D, Campagna G, Lucantoni F, Anastasi E, Pallotta L, Panimolle F, Leto G, Lenzi A, Leonetti F, Buzzetti R.

Diabetes Metab Res Rev. 2018 Nov;34(8):e3055. doi: 10.1002/dmrr.3055. Epub 2018 Aug 31.

PMID:
30129269
14.

Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using 18F-FDG PET and [U-13C]glucose Nuclear Magnetic Resonance Tracer.

Chung YH, Lu KY, Chiu SC, Lo CJ, Hung LM, Huang JP, Cheng ML, Wang CH, Tsai CK, Lin YC, Chang SH, Lin G.

Contrast Media Mol Imaging. 2018 Jul 12;2018:8751267. doi: 10.1155/2018/8751267. eCollection 2018.

15.

Glutamic Acid Decarboxylase Autoantibody-negative Slowly Progressive Type 1 Diabetes Mellitus: A Case Report and Literature Review.

Kobayashi M, Ohara N, Ikeda Y, Nagano O, Takada T, Kodama M, Sone H.

Intern Med. 2018 Dec 15;57(24):3581-3587. doi: 10.2169/internalmedicine.1008-18. Epub 2018 Aug 10.

16.

Sugar Beverages and Dietary Sodas Impact on Brain Health: A Mini Literature Review.

Anjum I, Jaffery SS, Fayyaz M, Wajid A, Ans AH.

Cureus. 2018 Jun 7;10(6):e2756. doi: 10.7759/cureus.2756. Review.

17.

Inhibition of SNAT5 Induces Incretin-Responsive State From Incretin-Unresponsive State in Pancreatic β-Cells: Study of β-Cell Spheroid Clusters as a Model.

Hashim M, Yokoi N, Takahashi H, Gheni G, Okechi OS, Hayami T, Murao N, Hidaka S, Minami K, Mizoguchi A, Seino S.

Diabetes. 2018 Sep;67(9):1795-1806. doi: 10.2337/db17-1486. Epub 2018 Jun 28.

PMID:
29954738
18.

Early onset and progression of non-alcoholic fatty liver disease in young monosodium l-glutamate-induced obese mice.

Coelho CFF, França LM, Nascimento JR, Dos Santos AM, Azevedo-Santos APS, Nascimento FRF, Paes AMA.

J Dev Orig Health Dis. 2018 Jun 1:1-8. doi: 10.1017/S2040174418000284. [Epub ahead of print]

PMID:
29855396
19.

Prolonged Exposure to Monosodium Glutamate in Healthy Young Adults Decreases Perceived Umami Taste and Diminishes Appetite for Savory Foods.

Noel CA, Finlayson G, Dando R.

J Nutr. 2018 Jun 1;148(6):980-988. doi: 10.1093/jn/nxy055.

PMID:
29796671
20.

Probiotics and nutraceuticals as a new frontier in obesity prevention and management.

Kobyliak N, Falalyeyeva T, Boyko N, Tsyryuk O, Beregova T, Ostapchenko L.

Diabetes Res Clin Pract. 2018 Jul;141:190-199. doi: 10.1016/j.diabres.2018.05.005. Epub 2018 May 26.

PMID:
29772287

Supplemental Content

Loading ...
Support Center